Completed

J-SUPPORT2104

A Randomized Controlled Trial of a Mobile-based Empathic Communication Support Program to Promote Advance Care Planning Discussion Between Advanced Cancer Patients and Physicians

J-SUPPORT2102

Interactive assistance via eHealth for small and medium-sized enterprises' employer and health care manager teams on tobacco control

J-SUPPORT2101

Randomized Controlled Trial to Develop a Program for Geriatric Assessment and Management by Mobile Applications for Elderly Patients with Advanced and Recurrent Cancer

J-SUPPORT2001

Optimizing smartphone psychotherapy for depression and anxiety among patients with cancer: multiphase optimization strategy [MOST] by using innovative clinical trial system

J-SUPPORT1902

Suicide, other externally caused injuries, and cardiovascular death following a cancer diagnosis: a nationwide population-based study in Japan

J-SUPPORT1901

A feasibility open trial of the case management to encourage uptake of cancer screening for people with schizophrenia in psychiatric outpatient clinics

J-SUPPORT1704

A randomized controlled trial of integrated support program for promoting empathietic communication among rapid progressive cancer patients, families and physicians

J-SUPPORT1703

Smartphone-based problem-solving treatment and behavioral activation intervention to reduce fear of recurrence in breast cancer patients-SMILE study：a randomized controlled trial

J-SUPPORT1702

Quality of palliative care for end-of-life cancer patients and retrospective cohort study of unsolved clinical question of palliative care from administrative claims data

J-SUPPORT1701

Efficacy of prophylactic use of hydrocolloid dressing for hand-foot skin reaction by multi targeted kinase inhibitors: a phase Ⅲ randomized, self-controlled study

J-SUPPORT1605

Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery: a randomized, double-blind, placebo-controlled trial

A randomized, double-blind, placebo-controlled phase III trial evaluating olanzapine 5mg combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: J-SUPPORT 1604